MedPath
FDA Approval

6% HETASTARCH IN 0.9% SODIUM CHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Effective Date
January 29, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydroxyethyl Starch(6 g in 100 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

HF Acquisition Co LLC, DBA HealthFirst

045657305

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

045657305

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

6% HETASTARCH IN 0.9% SODIUM CHLORIDE

Product Details

NDC Product Code
51662-1317
Application Number
BA740193
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 29, 2024
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 875Y4127EAClass: ACTIBQuantity: 6 g in 100 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 0.9 g in 100 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath